David Hager

1.2k total citations
30 papers, 865 citations indexed

About

David Hager is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Transplantation. According to data from OpenAlex, David Hager has authored 30 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 12 papers in Geriatrics and Gerontology and 5 papers in Transplantation. Recurrent topics in David Hager's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Heart Failure Treatment and Management (7 papers) and Renal Transplantation Outcomes and Treatments (5 papers). David Hager is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Heart Failure Treatment and Management (7 papers) and Renal Transplantation Outcomes and Treatments (5 papers). David Hager collaborates with scholars based in United States and Belgium. David Hager's co-authors include Rose Anne Kenny, Rebecca S. Boxer, Alison Kleppinger, Alan H.B. Wu, Stacey J. Wieczorek, Stephen S. Gottlieb, Padma Krishnaswamy, Robert H. Christenson, T G Rosano and Nancy Gardetto and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

David Hager

28 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hager United States 13 458 188 137 106 100 30 865
James B. McClurken United States 16 528 1.2× 606 3.2× 217 1.6× 142 1.3× 107 1.1× 42 1.1k
Marjolijn van Buren Netherlands 20 260 0.6× 90 0.5× 79 0.6× 25 0.2× 87 0.9× 65 1.2k
Mark L. McBride United States 18 950 2.1× 133 0.7× 45 0.3× 39 0.4× 13 0.1× 33 1.1k
Macaulay Onuigbo United States 19 354 0.8× 164 0.9× 25 0.2× 56 0.5× 39 0.4× 88 1.2k
Nairne Scott‐Douglas Canada 19 297 0.6× 262 1.4× 46 0.3× 18 0.2× 42 0.4× 54 1.2k
Şehsuvar Ertürk Türkiye 16 236 0.5× 284 1.5× 16 0.1× 114 1.1× 100 1.0× 61 1.1k
Amanda R. Vest United States 19 725 1.6× 582 3.1× 28 0.2× 29 0.3× 309 3.1× 106 1.4k
Liviu Segall Romania 15 154 0.3× 182 1.0× 24 0.2× 75 0.7× 136 1.4× 25 828
Anthony Steimle United States 13 1.5k 3.2× 382 2.0× 80 0.6× 13 0.1× 58 0.6× 19 1.9k
Dmitry Abramov United States 15 416 0.9× 189 1.0× 15 0.1× 22 0.2× 37 0.4× 110 736

Countries citing papers authored by David Hager

Since Specialization
Citations

This map shows the geographic impact of David Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hager more than expected).

Fields of papers citing papers by David Hager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hager. The network helps show where David Hager may publish in the future.

Co-authorship network of co-authors of David Hager

This figure shows the co-authorship network connecting the top 25 collaborators of David Hager. A scholar is included among the top collaborators of David Hager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hager. David Hager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hager, David, et al.. (2020). Primary care pharmacy technicians: Effect on pharmacist workload and patient access to clinical pharmacy services. American Journal of Health-System Pharmacy. 77(Supplement_4). S93–S99. 8 indexed citations
2.
3.
Hager, David, et al.. (2017). Creation of a certification requirement for pharmacists in direct patient care roles. American Journal of Health-System Pharmacy. 74(19). 1584–1589. 5 indexed citations
4.
Sollinger, Hans W., David Hager, Brenda Muth, et al.. (2014). Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients. Transplantation. 97(6). 612–617. 60 indexed citations
5.
Hager, David, et al.. (2014). Tacrolimus Trough Level at Discharge Predicts Acute Rejection in Moderately Sensitized Renal Transplant Recipients. Transplantation. 97(10). 986–991. 38 indexed citations
6.
Descourouez, Jillian L., et al.. (2012). Peripheral administration of antithymocyte globulins: A review of current literature. Transplantation Reviews. 27(1). 17–20. 3 indexed citations
7.
Boxer, Rebecca S., et al.. (2010). The 6‐Minute Walk Is Associated With Frailty and Predicts Mortality in Older Adults With Heart Failure. Congestive Heart Failure. 16(5). 208–213. 118 indexed citations
8.
Boxer, Rebecca S., Zhu Wang, Stephen J. Walsh, David Hager, & Rose Anne Kenny. (2008). The Utility of the 6‐Minute Walk Test as a Measure of Frailty in Older Adults with Heart Failure. The American Journal of Geriatric Cardiology. 17(1). 7–12. 54 indexed citations
9.
Abiose, Ademola K., et al.. (2004). Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy. The American Journal of Cardiology. 93(12). 1564–1566. 38 indexed citations
10.
Wieczorek, Stacey J., et al.. (2003). Correlation of B-type natriuretic peptide level to 6-min walk test performance in patients with left ventricular systolic dysfunction. Clinica Chimica Acta. 328(1-2). 87–90. 15 indexed citations
11.
Maisel, Alan S., et al.. (2002). A rapid BNP assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter study. Journal of the American College of Cardiology. 39. 201–201. 1 indexed citations
12.
Wieczorek, Stacey J., Alan H.B. Wu, Robert H. Christenson, et al.. (2002). A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation. American Heart Journal. 144(5). 834–839. 143 indexed citations
13.
14.
Wijns, William, et al.. (1994). Impact of Residual Coronary Stenosis On Timi Perfusion After Thrombolytic Therapy and Ptca in Patients With Acute Myocardial-infarction. DIAL (Catholic University of Leuven). 90(4). 221–221. 1 indexed citations
15.
Moyé, L A, Marc A. Pfeffer, C. C. Wun, et al.. (1994). Uniformity of captopril benefit in the SAVE study: subgroup analysis. European Heart Journal. 15(suppl B). 2–8. 71 indexed citations
16.
Hager, David & Arnold M. Katz. (1987). Management of Shock in Acute Myocardial Infarction: Changing Concepts; Past, Present and Future. Cardiology. 74(4). 286–296.
17.
Hager, David. (1987). [Cases of death following cell therapy].. PubMed. 112(41). 1596–1596. 2 indexed citations
18.
Nelson, Richard W., David Hager, & ED Zanjani. (1983). Renal lymphosarcoma with inappropriate erythropoietin production in a dog. Journal of the American Veterinary Medical Association. 182(12). 1396–1397. 31 indexed citations
19.
Cohn, Jay N., Joseph A. Franciosa, Gary S. Francis, et al.. (1982). Effect of Short-Term Infusion of Sodium Nitroprusside on Mortality Rate in Acute Myocardial Infarction Complicated by Left Ventricular Failure. New England Journal of Medicine. 306(19). 1129–1135. 145 indexed citations
20.
Copeland, Jack G., Marion A. Wieden, William E. Feinberg, et al.. (1981). Legionnaires’ Disease Following Cardiac Transplantation. CHEST Journal. 79(6). 669–671. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James B. McClurken Breakdown of academic impact, for papers by Marjolijn van Buren Breakdown of academic impact, for papers by Mark L. McBride Breakdown of academic impact, for papers by Macaulay Onuigbo Breakdown of academic impact, for papers by Nairne Scott‐Douglas Breakdown of academic impact, for papers by Şehsuvar Ertürk Breakdown of academic impact, for papers by Amanda R. Vest Breakdown of academic impact, for papers by Liviu Segall Breakdown of academic impact, for papers by Anthony Steimle Breakdown of academic impact, for papers by Dmitry Abramov
Rankless by CCL
2026